Theradome vs iRestore

Author: MyHairline Editorial Team Editorial review: MyHairline medical content review. Named clinician reviewer pending verified reviewer relationship and crawlable bio. Last updated: May 2026

Educational use only. This article is not medical advice. The Myhairline.ai analyzer is an educational classification tool and does not diagnose, treat, or prescribe. Treatment decisions belong with a board-certified dermatologist or qualified clinician.

The practical Theradome vs iRestore decision is not settled by the largest diode count or the boldest before-and-after gallery. It comes down to whether the device is cleared for your intended use, whether its schedule is realistic for you, what the return terms require, and how much uncertainty you accept in the evidence.

Fact check: Device prices, protocols, and warranty terms were checked against manufacturer and FDA pages on July 30, 2026. Sale prices and policies change, so verify the live product and policy pages before buying.

The Real Difference Between These Two Devices

Both Theradome and iRestore sell consumer low-level light or laser therapy helmets with FDA 510(k) clearances. That is important to understand upfront: a 510(k) decision means the FDA found the submitted device substantially equivalent to a legally marketed predicate for its stated use. It is not an approval of every marketing claim, and it does not prove that two cleared devices perform equally.

Theradome's PRO LH80 uses 80 laser diodes. iRestore's Professional model uses a combination of lasers and LEDs. A 2020 systematic review found that device factors such as exposure and pulsing may matter, while the number of diodes was not significantly associated with the change in hair density. That makes raw diode count a poor stand-alone buying rule.

The broader category has randomized, sham-controlled trials and multiple systematic reviews, but those results should not be treated as proof that one current retail helmet outperforms another. A 2025 meta-analysis found improved hair density for androgenetic alopecia compared with placebo, while also reporting substantial heterogeneity. Device-specific protocols and studied populations still matter.

Theradome vs iRestore at a Glance

Prices are promotional snapshots, not permanent list prices. Compare the final device, included accessories, return shipping obligations, restocking rules, and warranty registration requirements.

What the Clinical Evidence Actually Supports

Let's be blunt about the evidence hierarchy here.

The strongest trial data in non-surgical hair loss belongs to finasteride and minoxidil. The 1998 Kaufman et al. finasteride trials in the Journal of the American Academy of Dermatology and the 2002 Olsen et al. minoxidil trials in the same journal are the reference points. Both demonstrated significant effects versus placebo in stabilizing or modestly improving hair counts in men with androgenetic alopecia.

LLLT sits a tier below. The Jimenez et al. (2014) trial is legitimate, but the evidence base is thinner, the effect sizes more modest, and the replication less extensive. For PRP, the 2019 Journal of Dermatological Treatment meta-analysis pooled mixed-quality studies and found a small but statistically significant aggregate effect, though heterogeneity across studies was substantial.

So when you're comparing Theradome vs iRestore, you're comparing two devices in a category where the clinical evidence is real but not overwhelming. Neither device is snake oil. Neither device is finasteride. That's the boring truth, and it matters more than diode counts.

Price, Protocol, and the Stuff That Actually Varies

Where Theradome and iRestore genuinely differ is in the practical experience of using them.

Cost. At the time of verification, Theradome advertised the PRO LH80 at $995 and EVO LH40 at $695. iRestore's product collection showed the Professional at $799 and Essential at $499. These were sale prices and can move. Use the live total, warranty, and return conditions rather than an old comparison-page price.

Treatment time. Theradome currently states 20 minutes twice weekly for the PRO and four times weekly for the EVO. For iRestore, follow the instructions for the exact model you buy rather than assuming that one schedule applies to every device generation.

Comfort and design. Fit is not trivial when consistent use is required for months. Check device weight, contact points, controller placement, cord or battery requirements, and whether the coverage pattern matches the area you want to treat. Manufacturer claims about "full coverage" are not a substitute for trying the device under the return policy.

Warranty and return policy. Both companies offer return windows, though the specifics shift. Check current terms before purchasing. Theradome has historically offered a longer satisfaction guarantee.

None of these differences change the underlying biology. Red light at 650 to 680 nanometers hits your follicles whether it comes from a Theradome or an iRestore. The question is whether you'll actually use the device consistently for six to twelve months, because that's the minimum timeframe where any LLLT effect would become visible.

Why Most Comparison Articles Get This Wrong

Many device comparisons collapse a clinical question into a feature score. Diode counts, list prices, and badges are easy to rank, but they do not establish comparative effectiveness. Look for the exact 510(k) record, the model-specific protocol, a transparent evidence review, and a clearly disclosed commercial relationship.

The dermatology literature, rooted in Hamilton's foundational 1951 classification in the Annals of the New York Academy of Sciences and Norwood's 1975 work in the Southern Medical Journal, tells us that androgenetic alopecia is progressive and pattern-specific. The right intervention depends on where you are on that progression, your tolerance for medication side effects, and what outcomes you actually consider success.

A Norwood II patient who can't tolerate finasteride and wants a non-pharmaceutical adjunct to topical minoxidil? LLLT is a reasonable addition. A Norwood V patient expecting a laser helmet alone to regrow a full head of hair? That patient is going to be disappointed, regardless of which brand they choose.

A Better Way to Choose

Use this sequence instead of choosing a universal winner:

1. Confirm with a dermatologist that your hair loss is consistent with androgenetic alopecia. Sudden, patchy, painful, or inflamed hair loss needs a different workup.
2. Check the FDA clearance for the exact model and whether its indicated population matches you.
3. Compare the required weekly routine. The device you can follow consistently is more useful than one you abandon.
4. Read the live return and warranty terms, including minimum-use requirements, registration, shipping costs, and exclusions.
5. Set a baseline with standardized photographs before starting and agree on a reasonable review interval with your clinician.

If two devices meet those checks, choose based on the verified total cost and the schedule you are more likely to maintain. The available evidence does not support declaring a universal winner between these two brands.

The Device vs. Medication Reality Check

If you came here searching "theradome vs irestore" and you're not already using minoxidil or finasteride (or both), I'd respectfully suggest you're optimizing the wrong variable. It's like debating which premium tire to put on a car that doesn't have an engine.

For androgenetic alopecia, the medications have substantially more replicated trial evidence than any device. Low-level laser therapy has trial-level support, but smaller effect sizes. The most defensible treatment strategy starts with the well-evidenced interventions and adds devices as adjuncts, not replacements.

That said, some people genuinely cannot or will not take finasteride. Some people experience side effects with minoxidil. For those patients, LLLT represents a non-pharmaceutical option with some evidentiary support and a favorable safety profile. That's a legitimate use case, just not the one most comparison articles are written for.

Common Questions

Does Theradome or iRestore have stronger clinical evidence behind its specific device? The category has supportive randomized trials and systematic reviews, but this review did not find a head-to-head randomized trial of the current Theradome PRO LH80 against the current iRestore Professional. Brand-sponsored studies and broader device-class evidence cannot establish which of those two retail models is superior.

Is one device FDA-approved? Both are FDA-cleared via the 510(k) pathway, which demonstrates substantial equivalence to a predicate device. Neither has gone through the more rigorous PMA process used for new drugs.

Can I use a laser helmet instead of minoxidil or finasteride? You can, but the evidence base is substantially weaker. For androgenetic alopecia, finasteride and minoxidil remain the first-line treatments with the strongest trial data. LLLT devices are best understood as adjuncts.

Does the Myhairline.ai analyzer diagnose hair loss? No. The analyzer is an educational classification tool. It does not diagnose, treat, or prescribe. A clinical diagnosis of any hair loss condition requires examination by a board-certified dermatologist.

Are the treatment claims in this article guarantees? No. Every treatment discussed has documented variability in outcome across patients. No medication, procedure, or device guarantees regrowth, and no responsible clinician or article should claim otherwise.

Does "more diodes" mean better results? Not necessarily. Total energy delivered to the scalp matters, but so do wavelength, treatment duration, and adherence. A device with fewer diodes used consistently may outperform a device with more diodes used sporadically.

How long do I need to use a laser helmet before seeing results? Trials and manufacturer protocols use different timeframes. Follow the exact device instructions and agree on an evaluation period with a qualified clinician. Do not substitute a marketing timeline for a medical assessment.

Continue Reading

This article is part of the Comparisons & Decision-Making cluster on Myhairline.ai. The pillar overview is The Norwood Scale: Complete Guide to Male Pattern Hair Loss Stages, and the cluster hub is Comparisons & Decision-Making Cluster Hub.

Within this cluster:

• Keeps Vs Hims: a focused reference on keeps vs hims.
• Capillus Vs Irestore: a focused reference on capillus vs irestore.
• Him Vs Keeps: a focused reference on him vs keeps.

Related from other clusters:

• Finasteride Hims: Complete Guide: a focused reference on finasteride hims. (from the Non-Surgical Treatments cluster).
• Turkey Hair Transplant Cost - Real Numbers: a focused reference on turkey hair transplant cost. (from the Hair Transplant Cost & Process cluster).

Key References

• FDA 510(k) record for iRestore ID-500, K213094
• FDA 510(k) letter for Theradome LH80, K180460
• 2025 systematic review and meta-analysis of low-level laser and LED therapy
• 2020 systematic review of device and usage factors
• 2013 randomized, double-blind, sham-controlled helmet-device trial
• Theradome current model prices and protocols
• iRestore current product collection
• iRestore warranty policy